Copyright
©The Author(s) 2025.
World J Nephrol. Jun 25, 2025; 14(2): 100117
Published online Jun 25, 2025. doi: 10.5527/wjn.v14.i2.100117
Published online Jun 25, 2025. doi: 10.5527/wjn.v14.i2.100117
Figure 2 Level of serum phosphorus during each visit.
- Citation: Niranjan MR, Srinivasa S, Gupta V, Bhalla AK, Gaikwad A, Wangikar P, Suryawanshi S, Gajbe P. Sucroferric oxyhydroxide monotherapy for hyperphosphatemia in Indian chronic kidney disease patients undergoing hemodialysis: A phase IV, single-arm, open-label study. World J Nephrol 2025; 14(2): 100117
- URL: https://www.wjgnet.com/2220-6124/full/v14/i2/100117.htm
- DOI: https://dx.doi.org/10.5527/wjn.v14.i2.100117